Patent ID: 11905328
Assignee: IMMATICS BIOTECHNOLOGIES GMBH
Field: Biotechnology (Chemistry)
Classification: CPC C | IPC C

Claim 8:
9. The dual specificity polypeptide molecule according to claim 1, wherein the cell surface molecule is known to induce the activation of immune cells, or is at least one selected from the group consisting of CD3γ, CD3δ, CD3ε, CD4, CD7, CD8, CD10, CD11b, CD11c, CD14, CD16, CD18, CD22, CD25, CD28, CD32a, CD32b, CD33, CD41, CD41b, CD42a, CD42b, CD44, CD45RA, CD49, CD55, CD56, CD61, CD64, CD68, CD94, CD90, CD117, CD123, CD125, CD134, CD137, CD152, CD163, CD193, CD203c, CD235a, CD278, CD279, CD287, Nkp46, NKG2D, GITR, FcεRI, TCRα/β, TCRγ/δ, and HLA-DR.